한글목차

세계의 에피제네틱스 시장은 2024년에 18억 6,000만 달러로 평가되며, 2030년까지 CAGR 8.17%로 성장하며, 29억 8,000만 달러에 달할 것으로 예측됩니다. 후성유전학은 DNA 염기서열 자체를 바꾸지 않고 유전자의 발현에 발생하는 유전적 변화를 연구하는 분야로, 유전자의 활성화와 비활성화에 영향을 미쳐 세포 과정과 질병의 진행에 관여합니다. 시장 확대는 주로 만성질환, 특히 암의 전 세계 유병률 증가에 의해 주도되고 있으며, 후성유전학적 변형은 질병의 발병과 치료 반응에 중요한 역할을 하고 있습니다.

주요 시장 성장 촉진요인

세계에서 암 이환율과 사망률 증가 추세가 뚜렷하고, 종양 발생과 진행에 있으며, 후성유전학적 변화가 차지하는 확고한 역할을 고려할 때, 후성유전학 시장이 크게 성장하고 있습니다. 후성유전학적 진단 및 치료법은 조기 발견, 예후 예측, 치료 전략의 새로운 길을 제시하여 시급한 미충족 의료 수요에 대응하고 있습니다.

주요 시장 과제

첨단 후성유전학 연구 및 진단 기술과 관련된 막대한 비용은 세계 후성유전학 시장의 성장에 큰 장벽으로 작용하고 있습니다. 이러한 막대한 비용은 소규모 연구기관과 신생 의료기관의 접근을 직접적으로 제한하고, 필요한 장비, 전문 인력, 대규모 임상시험에 대한 투자를 가로막고 있습니다.

주요 시장 동향

노화 및 장수 연구에서의 후성유전학의 적용은 기존의 질병 중심 모델을 넘어 건강수명 연장에 초점을 맞추는 큰 성장 분야입니다. 후성유전학적 변형은 노화 과정과 노화 관련 질환의 근본적인 촉진요인으로 점점 더 많이 인식되고 있으며, 이러한 변화를 조절하는 중재 방법에 대한 막대한 투자를 촉진하고 있습니다.

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 에피제네틱스 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 제품·서비스별(키트·시약, 효소, 기기·부속품, 소프트웨어, 서비스)
  • 기술별(DNA 메틸화, 히스톤 메틸화, 기타)
  • 최종사용자별(학술연구기관, 제약회사 및 바이오테크놀러지 기업, CRO, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 에피제네틱스 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 에피제네틱스 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 에피제네틱스 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 에피제네틱스 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 에피제네틱스 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 합병·인수
• 제품 출시
• 최근 동향

제13장 세계의 에피제네틱스 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Abcam Limited
• Active Motif Inc
• Hologic, Inc.
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Qiagen N.V.
• Thermo Fisher Scientific Inc
• Novartis AG
• Element Biosciences
• Dovetail Genomics LLC

제16장 전략적 제안

제17장 조사회사 소개·면책사항

영문목차

The Global Epigenetic Market, valued at USD 1.86 Billion in 2024, is projected to experience a CAGR of 8.17% to reach USD 2.98 Billion by 2030. Epigenetics encompasses the study of heritable changes in gene expression that occur without altering the underlying DNA sequence, influencing how genes are activated or silenced to affect cellular processes and disease progression. The market's expansion is primarily driven by the increasing global prevalence of chronic diseases, particularly cancer, where epigenetic modifications play a crucial role in disease development and treatment response.

Key Market Drivers

The increasing burden of cancer incidence and mortality rates globally significantly drives the epigenetic market, given the established role of epigenetic alterations in tumorigenesis and progression. Epigenetic diagnostics and therapeutics offer novel avenues for early detection, prognosis, and treatment strategies, responding to an urgent unmet medical need.

Key Market Challenges

The substantial costs associated with advanced epigenetic research and diagnostic technologies pose a significant impediment to the global epigenetic market's growth. These considerable expenses directly limit accessibility for smaller research institutions and emerging healthcare providers, preventing them from investing in necessary equipment, specialized personnel, and extensive clinical trials. Such financial barriers restrict the widespread adoption of innovative epigenetic tools and therapies, particularly in regions with constrained healthcare budgets, thereby slowing overall market penetration and expansion.

Key Market Trends

The application of epigenetics in aging and longevity research represents a substantial area of growth, moving beyond traditional disease-centric models to focus on healthspan extension. Epigenetic modifications are increasingly recognized as fundamental drivers of the aging process and age-related conditions, prompting significant investment in interventions to modulate these changes.

Key Market Players

• Abcam Limited
• Active Motif Inc
• Hologic, Inc.
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Qiagen N.V.
• Thermo Fisher Scientific Inc
• Novartis AG
• Element Biosciences
• Dovetail Genomics LLC

Report Scope:

In this report, the Global Epigenetic Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Epigenetic Market, By Product & Service:

• Kits & Reagents
• Enzymes
• Instruments & Accessories
• Software
• Services

Epigenetic Market, By Technology:

• DNA Methylation
• Histone Methylation
• Others

Epigenetic Market, By End user:

• Academic and Research Institutes
• Pharmaceutical Companies and Biotechnology Companies
• Contract Research Organizations
• Others

Epigenetic Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Epigenetic Market.

Available Customizations:

Global Epigenetic Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Epigenetic Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Service (Kits & Reagents, Enzymes, Instruments & Accessories, Software, Services)
  • 5.2.2. By Technology (DNA Methylation, Histone Methylation, Others)
  • 5.2.3. By End user (Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Epigenetic Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Service
  • 6.2.2. By Technology
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Epigenetic Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Service
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By End user
  • 6.3.2. Canada Epigenetic Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Service
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By End user
  • 6.3.3. Mexico Epigenetic Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Service
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By End user

7. Europe Epigenetic Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Service
  • 7.2.2. By Technology
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Epigenetic Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Service
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By End user
  • 7.3.2. France Epigenetic Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Service
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Epigenetic Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Service
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Epigenetic Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Service
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Epigenetic Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Service
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By End user

8. Asia Pacific Epigenetic Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Service
  • 8.2.2. By Technology
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Epigenetic Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Service
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By End user
  • 8.3.2. India Epigenetic Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Service
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By End user
  • 8.3.3. Japan Epigenetic Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Service
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By End user
  • 8.3.4. South Korea Epigenetic Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Service
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Epigenetic Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Service
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By End user

9. Middle East & Africa Epigenetic Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Service
  • 9.2.2. By Technology
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Epigenetic Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Service
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By End user
  • 9.3.2. UAE Epigenetic Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Service
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By End user
  • 9.3.3. South Africa Epigenetic Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Service
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By End user

10. South America Epigenetic Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Service
  • 10.2.2. By Technology
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Epigenetic Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Service
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By End user
  • 10.3.2. Colombia Epigenetic Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Service
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By End user
  • 10.3.3. Argentina Epigenetic Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Service
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Epigenetic Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abcam Limited
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Active Motif Inc
• 15.3. Hologic, Inc.
• 15.4. F. Hoffmann-La Roche Ltd.
• 15.5. Illumina, Inc.
• 15.6. Qiagen N.V.
• 15.7. Thermo Fisher Scientific Inc
• 15.8. Novartis AG
• 15.9. Element Biosciences
• 15.10. Dovetail Genomics LLC

16. Strategic Recommendations

17. About Us & Disclaimer